TrialNature medicine2024

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Jianjun Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.